By PTI
NEW DELHI: The Central Drugs Standard Control Organisation (CDSCO) has initiated a probe in reference to the demise of 18 youngsters in Uzbekistan allegedly linked to a cough syrup manufactured by an Indian agency, official sources stated on Thursday.
The well being ministry of Uzbekistan has claimed that the kids who died had consumed cough syrup ‘Doc-1 Max’ manufactured by Noida-based Marion Biotech.
Hasan Harris, authorized consultant of Mario Biotech, stated the governments of each international locations is wanting into the matter and inquiring.
“There is no problem from our end and no issue in testing. We have been there for the past ten years. Once the government report will come, we will look into it. For now the manufacturing has stopped,” Harris stated.
According to the ministry, chemical ethylene glycol was present in a batch of syrup throughout laboratory checks.
Sources stated the Drugs Controller General of India has sought extra data concerning the incident from the Uzbek regulator.
An inspection collectively performed by the central medication regulatory crew of north zone and state medication regulatory crew was additionally taken throughout which samples of the medication have been additionally lifted.
Earlier this 12 months, demise of 70 youngsters in Gambia was linked to cough syrups manufactured by Haryana-based Maiden Pharmaceuticals following which the Haryana based mostly unit was shut for violation of producing requirements.
However, later the samples examined in a authorities laboratory in India have been discovered to be complying with specs.
NEW DELHI: The Central Drugs Standard Control Organisation (CDSCO) has initiated a probe in reference to the demise of 18 youngsters in Uzbekistan allegedly linked to a cough syrup manufactured by an Indian agency, official sources stated on Thursday.
The well being ministry of Uzbekistan has claimed that the kids who died had consumed cough syrup ‘Doc-1 Max’ manufactured by Noida-based Marion Biotech.
Hasan Harris, authorized consultant of Mario Biotech, stated the governments of each international locations is wanting into the matter and inquiring.
“There is no problem from our end and no issue in testing. We have been there for the past ten years. Once the government report will come, we will look into it. For now the manufacturing has stopped,” Harris stated.
According to the ministry, chemical ethylene glycol was present in a batch of syrup throughout laboratory checks.
Sources stated the Drugs Controller General of India has sought extra data concerning the incident from the Uzbek regulator.
An inspection collectively performed by the central medication regulatory crew of north zone and state medication regulatory crew was additionally taken throughout which samples of the medication have been additionally lifted.
Earlier this 12 months, demise of 70 youngsters in Gambia was linked to cough syrups manufactured by Haryana-based Maiden Pharmaceuticals following which the Haryana based mostly unit was shut for violation of producing requirements.
However, later the samples examined in a authorities laboratory in India have been discovered to be complying with specs.